English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusCompleted
Sponsors
Federal University of São Paulo
Collaborators
Fundação de Amparo à Pesquisa do Estado de São Paulo

Keywords

Abstract

The study aimed to evaluate the chronic effects of resistance training on blood pressure and biochemical exams in hypertensive elderlies and the influence of the polymorphism of the angiotensin converting enzyme in these response.

Description

To investigate the chronic effects of resistance training on blood pressure and biochemical exams in elderly, 135 hypertensive elderlies were divided into 2 groups: trained and control. The trained group was submitted to a resistance training period. Before the 16 weeks ACE gene was genotyped (PCR). Before and after 16 weeks, blood pressure (ambulatory), HDL-cholesterol, Total cholesterol, Glycemia, Triacylglycerol (colorimetric assay) and plasminogen activator inhibition (PAI-1), intercellular adhesion molecule (ICAM-1), vascular endothelial cell adhesion molecule (VCAM-1), Adiponectin, tumor necrosis factor alpha (TNF-alpha), C Reactive Protein, Angiotensin II, Angiotensin Converting Enzyme, Angiotensin 1-7, (ELISA assay) were measured.

Dates

Last Verified: 09/30/2013
First Submitted: 10/08/2013
Estimated Enrollment Submitted: 10/10/2013
First Posted: 10/15/2013
Last Update Submitted: 10/10/2013
Last Update Posted: 10/15/2013
Actual Study Start Date: 03/31/2010
Estimated Primary Completion Date: 03/31/2013
Estimated Study Completion Date: 03/31/2013

Condition or disease

Hypertension

Intervention/treatment

Behavioral: Resistance training

Phase

-

Arm Groups

ArmIntervention/treatment
Experimental: Resistance training
Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR).
Behavioral: Resistance training
Resistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR).
No Intervention: Control

Eligibility Criteria

Ages Eligible for Study 60 Years To 60 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- Hypertensives

- Age 60 to 85 years

- Nonactive

Exclusion Criteria:

- Orthopedic problems or other problem that prevented the exercises

- Change in drug treatment during protocol

- Absence in more than 25% of the exercise sessions

Outcome

Primary Outcome Measures

1. Blood Pressure [16 weeks]

Blood pressure was measured by Ambulatorial Monitoring Blood Pressure before and after 16 weeks of intervention.

Secondary Outcome Measures

1. HDL-cholesterol [16 weeks]

HDL-cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.

2. Total Cholesterol [16 weeks]

Total cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.

3. Glycemia [16 weeks]

Glycemia was analyzed by colorimetric assay, before and after 16 weeks of intervention.

4. Triacylglycerol [16 weeks]

Triacylglycerol was analyzed by colorimetric assay, before and after 16 weeks of intervention.

5. PAI-1 [16 weeks]

PAI-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.

6. ICAM-1 [16 weeks]

ICAM-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.

7. VCAM-1 [16 weeks]

VCAM-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.

8. Adiponectin [16 weeks]

Adiponectin was analyzed by ELISA assay, before and after 16 weeks of intervention.

9. TNF alpha [16 weeks]

TNF alpha was analyzed by ELISA assay, before and after 16 weeks of intervention.

10. C Reactive Protein [16 weeks]

C Reactive Protein was analyzed by ELISA assay, before and after 16 weeks of intervention.

11. Angiotensin II [16 weeks]

Angiotensin II was analyzed by ELISA assay, before and after 16 weeks of intervention.

12. Angiotensin Converting Enzyme [16 weeks]

Angiotensin Converting Enzyme was analyzed by ELISA assay, before and after 16 weeks of intervention.

13. Angiotensin 1-7 [16 weeks]

Angiotensin 1-7 was analyzed by ELISA assay, before and after 16 weeks of intervention.

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge